BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24796539)

  • 1. Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.
    Zuhlke KA; Johnson AM; Tomlins SA; Palanisamy N; Carpten JD; Lange EM; Isaacs WB; Cooney KA
    Prostate; 2014 Jun; 74(9):983-90. PubMed ID: 24796539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
    Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
    PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
    Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
    APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
    Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
    Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPOP mutations in prostate cancer across demographically diverse patient cohorts.
    Blattner M; Lee DJ; O'Reilly C; Park K; MacDonald TY; Khani F; Turner KR; Chiu YL; Wild PJ; Dolgalev I; Heguy A; Sboner A; Ramazangolu S; Hieronymus H; Sawyers C; Tewari AK; Moch H; Yoon GS; Known YC; Andrén O; Fall K; Demichelis F; Mosquera JM; Robinson BD; Barbieri CE; Rubin MA
    Neoplasia; 2014 Jan; 16(1):14-20. PubMed ID: 24563616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genomic features of SPOP-mutant prostate cancer.
    Nakazawa M; Fang M; H Marshall C; Lotan TL; Isaacsson Velho P; Antonarakis ES
    Prostate; 2022 Feb; 82(2):260-268. PubMed ID: 34783071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
    Zuhlke KA; Johnson AM; Okoth LA; Stoffel EM; Robbins CM; Tembe WA; Salinas CA; Zheng SL; Xu J; Carpten JD; Lange EM; Isaacs WB; Cooney KA
    Fam Cancer; 2012 Dec; 11(4):595-600. PubMed ID: 22864661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
    Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of speckle type BTB/POZ protein mutation regulated key metabolic pathways by cell based proteomics and metabolomics].
    Yan M; Liu J; Xia T; Xu G; Piao H
    Se Pu; 2019 Aug; 37(8):887-896. PubMed ID: 31642260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations in HOXB13 and prostate-cancer risk.
    Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
    N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
    White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation.
    Lv W; Huan M; Yang W; Gao Y; Wang K; Xu S; Zhang M; Ma J; Wang X; Chen Y; Li L
    Biochem Biophys Res Commun; 2020 Aug; 529(3):799-804. PubMed ID: 32736710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
    Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
    Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of SPOP in DNA Damage Response and DNA Replication.
    Maekawa M; Higashiyama S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of speckle-type POZ protein (SPOP) in cancer development.
    Mani RS
    Drug Discov Today; 2014 Sep; 19(9):1498-502. PubMed ID: 25058385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
    Fontugne J; Cai PY; Alnajar H; Bhinder B; Park K; Ye H; Beg S; Sailer V; Siddiqui J; Blattner-Johnson M; Croyle JA; Noorzad Z; Calagua C; MacDonald TY; Axcrona U; Bogaard M; Axcrona K; Scherr DS; Sanda MG; Johannessen B; Chinnaiyan AM; Elemento O; Skotheim RI; Rubin MA; Barbieri CE; Mosquera JM
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35050902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
    Shi Q; Zhu Y; Ma J; Chang K; Ding D; Bai Y; Gao K; Zhang P; Mo R; Feng K; Zhao X; Zhang L; Sun H; Jiao D; Chen Y; Sun Y; Zhao SM; Huang H; Li Y; Ren S; Wang C
    Mol Cancer; 2019 Nov; 18(1):170. PubMed ID: 31771591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
    Zhu Y; Wen J; Huang G; Mittlesteadt J; Wen X; Lu X
    Prostate; 2021 Jan; 81(1):81-88. PubMed ID: 33022763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
    Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.